GO:0007517 muscle organ development: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007517 (muscle organ development) describes the progression of muscle from formation to mature structure, producing contractile tissue for movement and mechanical work.
• Muscle organ development is orchestrated by myogenic regulatory factors, signaling pathways, and non-coding RNAs that control proliferation, differentiation, and fusion of myoblasts.
• Single-cell transcriptomics has revealed conserved and species-specific trajectories of muscle progenitor cells during organogenesis.
• Disruption of muscle organ development contributes to atrophy, myopathies, and metabolic disease, making it a key target for therapeutic research.
• Connexins and gap junctions are essential for coordinating electrical and metabolic signals during skeletal muscle development.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes within GO:0007517.
Description
Muscle organ development (GO:0007517) is the biological process by which muscle tissue progresses from its initial formation to a mature, functional organ capable of contraction and mechanical work. This process encompasses the specification of muscle progenitors, their proliferation and differentiation, and the assembly of contractile structures within elongated muscle cells. Understanding GO:0007517 is fundamental for developmental biology, regenerative medicine, and the study of muscle-related diseases such as atrophy and myopathies. Recent advances in single-cell transcriptomics have provided a high-resolution view of the cellular trajectories that underlie muscle organ development across mammalian species. In parallel, studies in model organisms such as Drosophila have uncovered conserved genetic programs that drive myogenesis and muscle maturation. Non-coding RNAs, including microRNAs and circular RNAs, have emerged as critical regulators of muscle gene expression during development and in disease. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to provide a research-grade overview of GO:0007517, its molecular players, and the experimental methods used to study it.
muscle organ development At A Glance
| GO ID | GO:0007517 |
|---|---|
| GO term | muscle organ development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Progression of muscle from formation to mature contractile organ |
| Definition source | QuickGO |
| Related processes | Myogenesis, myoblast differentiation, muscle cell fusion, sarcomere assembly |
| Key regulators | Myogenic regulatory factors (MYOD1, MYF5, MYOG, MRF4), microRNAs, connexins |
| Disease relevance | Muscle atrophy, myopathies, metabolic disorders, musculoskeletal diseases |
What Is GO:0007517?
According to the Gene Ontology, GO:0007517 (muscle organ development) is defined as the process whose specific outcome is the progression of the muscle over time, from its formation to the mature structure. The muscle is an organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work. In practical terms, this term covers all cellular and molecular events that convert muscle progenitor cells into a functional contractile organ, including myoblast specification, differentiation, fusion, and maturation of the contractile apparatus.
Why Is muscle organ development Important in Cell Biology?
Muscle organ development is essential for organismal movement, posture, and metabolic homeostasis, and its disruption underlies a wide range of human diseases including congenital myopathies, age-related sarcopenia, and cancer cachexia. Because muscle is one of the most abundant tissues in the body, understanding how it forms and matures has direct implications for regenerative medicine, tissue engineering, and the development of therapies for muscle-wasting conditions. Moreover, conserved genetic programs identified in model organisms continue to inform human muscle biology and disease mechanisms.
• Provides the cellular basis for locomotion, breathing, and posture.
• Dysregulation leads to muscle atrophy and hypertrophy disorders.
• Implicated in congenital and acquired myopathies.
• Linked to metabolic homeostasis through muscle-adipose crosstalk.
• MicroRNAs fine-tune muscle gene expression during development and disease.
• Connexin-mediated communication is required for proper muscle development.
• Single-cell atlases reveal conserved developmental trajectories.
• Drosophila myogenesis offers a genetically tractable model for conserved mechanisms.
• Circular RNAs are emerging players in musculoskeletal disease.
• Poultry myopathies such as woody breast highlight agricultural relevance.
What Happens During muscle organ development?
Specification of muscle progenitors
In simple terms: Early embryonic cells receive signals that tell them to become muscle-forming cells.
During embryogenesis, paraxial mesoderm cells are specified into myogenic progenitors under the control of signaling pathways and transcription factors such as MYF5 and MYOD1. In Drosophila, similar specification events are governed by conserved myogenic regulatory networks. Single-cell transcriptomic studies have mapped the emergence of muscle progenitor populations across mammalian organogenesis.
Proliferation and differentiation of myoblasts
In simple terms: Muscle precursor cells multiply and then stop dividing to become specialized muscle cells.
Myoblasts proliferate in response to growth factors and then exit the cell cycle to differentiate, a transition controlled by MYOG and MRF4. MicroRNAs such as miR-1 and miR-133 modulate this balance by targeting components of the myogenic program. Disruption of this step can lead to impaired muscle formation and disease.
Myoblast fusion and myotube formation
In simple terms: Individual muscle cells fuse together to form long, multi-nucleated fibers.
Fusion of myoblasts into multinucleated myotubes requires coordinated membrane remodeling and cytoskeletal reorganization. Connexins form gap junctions that facilitate electrical and metabolic coupling during this process. Defects in fusion are associated with muscle developmental disorders.
Maturation and sarcomere assembly
In simple terms: The fused muscle fibers organize their internal contractile machinery to become fully functional.
Maturation involves the assembly of sarcomeres, the basic contractile units, and the establishment of neuromuscular junctions. This stage is regulated by mechanical cues and metabolic signals, including adipokines and lipokines from adipose tissue. Circular RNAs have been implicated in the regulation of musculoskeletal maturation and disease.
Postnatal growth and regeneration
In simple terms: After birth, muscles grow and can repair themselves using resident stem cells.
Satellite cells, the resident muscle stem cells, contribute to postnatal growth and regeneration. Their activation is controlled by signaling pathways such as mTOR and by microRNAs. Impaired regeneration is a hallmark of sarcopenia and muscular dystrophies.
Key Genes Involved in GO:0007517 muscle organ development
The following genes and proteins are central to muscle organ development (GO:0007517) and are frequently studied in developmental and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOD1 | Myogenic determination factor | Master regulator of myoblast differentiation |
| MYF5 | Myogenic specification | Early muscle progenitor commitment |
| MYOG | Myogenin, differentiation factor | Terminal differentiation of myoblasts |
| MRF4 | Myogenic regulatory factor | Muscle maturation and maintenance |
| MEF2C | Transcription factor | Cooperates with MRFs in muscle gene activation |
| PAX3 | Paired box transcription factor | Specification of muscle progenitors |
| PAX7 | Satellite cell marker | Muscle stem cell maintenance and regeneration |
| GJA1 (Connexin 43) | Gap junction protein | Electrical coupling in developing muscle |
| GJB1 (Connexin 32) | Gap junction protein | Intercellular communication in muscle |
| MIR1-1 | MicroRNA | Promotes myogenesis, targets HDAC4 |
| MIR133A | MicroRNA | Regulates myoblast proliferation |
| MSTN | Myostatin | Negative regulator of muscle growth |
| IGF1 | Growth factor | Promotes muscle hypertrophy |
| FOXO1 | Transcription factor | Mediates muscle atrophy pathways |
| AKT1 | Kinase | mTOR pathway activation in hypertrophy |
| MTOR | Kinase | Central regulator of protein synthesis in muscle |
| CIRCRNA_HRCR | Circular RNA | Modulates musculoskeletal disease pathways |
How Is muscle organ development Regulated?
Muscle organ development is regulated at multiple levels, including transcriptional control by myogenic regulatory factors (MYOD1, MYF5, MYOG, MRF4) and MEF2 family proteins. Signaling pathways such as IGF1-AKT-mTOR promote protein synthesis and hypertrophy, while FOXO-mediated pathways drive atrophy. MicroRNAs fine-tune the expression of these regulators, with miR-1 and miR-133 playing opposing roles in differentiation and proliferation. Adipokines and lipokines secreted by adipose tissue also influence muscle homeostasis and development. Connexin-mediated gap junction communication provides an additional layer of regulation by coordinating electrical and metabolic signals between developing muscle cells.
muscle organ development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FOXO1 | Muscle atrophy | Knockout mouse, overexpression in C2C12 |
| MTOR | Hypertrophy / atrophy | Conditional knockout, point mutation |
| MSTN | Muscle hyperplasia | Knockout in livestock, knock-in reporter |
| GJA1 | Myopathy with connexin defects | Knockout, point mutation in zebrafish |
| MIR1-1 | Muscle differentiation defects | Overexpression, knockout in mice |
Muscle atrophy and hypertrophy disorders
Imbalances in the signaling pathways that control muscle organ development lead to atrophy (loss of muscle mass) or hypertrophy (excessive growth). Key regulators include the IGF1-AKT-mTOR axis and FOXO transcription factors, which are often dysregulated in cachexia, sarcopenia, and disuse atrophy.
Myopathies and musculoskeletal diseases
Congenital and acquired myopathies often arise from mutations in genes that govern muscle development and maintenance. Circular RNAs and microRNAs have been implicated in the pathogenesis of musculoskeletal diseases, offering potential biomarkers and therapeutic targets.
Metabolic crosstalk and muscle homeostasis
Adipose tissue-derived adipokines and lipokines regulate skeletal muscle development and homeostasis, linking obesity and metabolic syndrome to muscle dysfunction. Disruption of this crosstalk can exacerbate insulin resistance and muscle wasting.
Agricultural and veterinary relevance
In commercial broilers, conditions such as woody breast myopathy affect internal organ and skeletal muscle development, highlighting the importance of muscle developmental biology in poultry production.
From muscle organ development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive myoblast differentiation? | Knockout in C2C12 or primary myoblasts |
| Does mutation Y affect sarcomere assembly? | Point mutation knock-in in zebrafish |
| Where is protein Z localized during development? | Tagged knock-in (e.g., GFP) in mouse |
| Does overexpression of gene W cause hypertrophy? | Overexpression in mouse muscle or C2C12 |
| Which genes regulate muscle stem cell quiescence? | CRISPR library screening in satellite cells |
| How do non-coding RNAs affect muscle development? | Knockout/overexpression of microRNA or circRNA |
How to Study the muscle organ development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| scRNA-seq | Cell-type-specific transcriptomes | Mapping muscle progenitor trajectories |
| CRISPR screen | Gene essentiality for muscle phenotypes | Identifying novel regulators |
| Immunofluorescence | Protein localization and sarcomere structure | Assessing muscle maturation |
| RNA-seq | Global gene expression changes | Comparing wild-type and mutant muscle |
| Small RNA-seq | MicroRNA expression | Profiling non-coding regulators |
| Proteomics | Protein abundance and modifications | Validating signaling pathways |
| Electron microscopy | Ultrastructure of sarcomeres | Detailing contractile apparatus |
| Gap junction assays | Intercellular communication | Evaluating connexin function |
Single-cell RNA sequencing
Single-cell transcriptomics enables the mapping of muscle progenitor trajectories and the identification of novel regulators during organogenesis.
CRISPR-based functional screens
Pooled CRISPR screens can systematically identify genes required for myoblast proliferation, differentiation, and fusion, accelerating the discovery of new players in GO:0007517.
Imaging and histology
Immunofluorescence and live imaging of sarcomeric proteins and gap junctions reveal structural defects in muscle development.
Molecular profiling of non-coding RNAs
RNA-seq and small RNA-seq quantify microRNA and circular RNA expression during muscle development and disease.
How CRISPR Can Be Used to Study GO:0007517 muscle organ development
Knockout
CRISPR knockout of candidate genes in myoblasts or animal models can reveal their requirement for muscle organ development. For example, knocking out MYOD1 or MYOG blocks differentiation, while FOXO1 knockout affects atrophy pathways.
Point Mutation
Introducing precise point mutations that mimic human disease variants allows researchers to test their impact on muscle development and function. This is particularly useful for sarcomeric and gap junction genes.
Knock-in
Knock-in of fluorescent tags or reporter cassettes enables live tracking of muscle progenitors and proteins during development. Tagged knock-in of PAX7 or MYOD1 can visualize cell fate decisions.
Overexpression
Overexpression of growth factors or non-coding RNAs can drive hypertrophy or alter differentiation. For instance, overexpression of IGF1 or miR-1 modulates muscle growth and development.
How EDITGENE Supports muscle organ development Research
Researchers studying muscle organ development-related genes often need to determine whether a candidate gene is causally involved in myogenesis, maturation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for muscle organ development research.
Frequently Asked Questions About muscle organ development
What is GO:0007517?
GO:0007517 is the Gene Ontology term for muscle organ development, the process by which muscle progresses from formation to a mature contractile organ.
What genes are involved in muscle organ development?
Key genes include MYOD1, MYF5, MYOG, MRF4, PAX3, PAX7, and MEF2C, among others.
How is muscle organ development regulated?
It is regulated by myogenic transcription factors, signaling pathways such as IGF1-AKT-mTOR, microRNAs, and connexin-mediated communication.
What diseases are linked to muscle organ development?
Disorders include muscle atrophy, hypertrophy, congenital myopathies, and metabolic conditions affecting muscle homeostasis.
What model organisms are used to study muscle development?
Common models include mice, zebrafish, Drosophila, and cell lines such as C2C12.
How can CRISPR be used to study muscle organ development?
CRISPR enables knockout, point mutation, knock-in, and overexpression of candidate genes to test their function in muscle development.
What is the role of microRNAs in muscle development?
MicroRNAs such as miR-1 and miR-133 fine-tune myoblast proliferation and differentiation.
What is the role of connexins in muscle development?
Connexins form gap junctions that coordinate electrical and metabolic signals during muscle development.
How does single-cell RNA sequencing help study muscle development?
It maps cellular trajectories and identifies novel progenitor populations and regulators.
What are circular RNAs and how do they relate to muscle disease?
Circular RNAs are non-coding RNAs implicated in musculoskeletal diseases and muscle development.
Conclusion
Muscle organ development (GO:0007517) is a complex, multi-stage process governed by conserved transcription factors, signaling pathways, and non-coding RNAs. Understanding its molecular underpinnings is essential for addressing muscle-wasting diseases and for advancing regenerative medicine. CRISPR-based models and single-cell technologies continue to accelerate the discovery of new regulators and therapeutic targets in this field.
References
- 1. Sartori R et al.. 2021. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease.. Nat Commun 12(1):330 PMID: 33436614
- 2. Cao J et al.. 2019. The single-cell transcriptional landscape of mammalian organogenesis.. Nature 566(7745):496-502 PMID: 30787437
- 3. Jia L et al.. 2022. Internal organ and skeletal muscle development in commercial broilers with woody breast myopathy.. Poult Sci 101(9):102012 PMID: 35896053
- 4. Merrifield PA et al.. 2016. Connexins in skeletal muscle development and disease.. Semin Cell Dev Biol 50:67-73 PMID: 26688333
- 5. Yu P et al.. 2025. CircularRNA and Musculoskeletal Diseases.. Adv Exp Med Biol 1485:437-448 PMID: 40886290
- 6. Bothe I et al.. 2016. Drosophila myogenesis.. Curr Biol 26(17):R786-91 PMID: 27623256
- 7. Gu X et al.. 2023. Adipose tissue adipokines and lipokines: Functions and regulatory mechanism in skeletal muscle development and homeostasis.. Metabolism 139:155379 PMID: 36538987
- 8. Diniz GP et al.. 2016. Regulation of Skeletal Muscle by microRNAs.. Compr Physiol 6(3):1279-94 PMID: 27347893
